Cite

HARVARD Citation

    Danese, M. et al. (2016). Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data. Medical care. 54 (4), p. . [Online]. 
  
Back to record